Skip to main content
Fig. 1 | BMC Psychiatry

Fig. 1

From: Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohort

Fig. 1

aDefined using the International Diabetes Federation definition; bBMI by 10 kg.m-2. cEstimated risk of death from cardiovascular diseases within 10 years using the Systematic Coronary Risk Estimation. Models were adjusted for age, sex, smoking status, and psychotropic medication (classified by the risk of weight gain), except the model for CVD which was adjusted only for psychotropic medication. 1Models fitted with random effect at observation level. 2Models fitted with random effect at patient level. ***:p-value < 0.001; **:p-value ≤ 0.01. *:p-value ≤ 0.05. Correction for multiple testing was applied using false discovery rate. Abbreviations: BMI body mass index, CVD cardiovascular diseases, HDL high-density lipoprotein, MetS metabolic syndrome, N number

Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us